The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s renal biomarkers market report forecasts the renal biomarkers market size to grow to $1.56 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Renal Biomarkers Market Report 2023 – https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report

Renal Biomarkers Market Size Forecast
The global renal biomarkers market is expected to grow from $1.07 billion in 2022 to $1.16 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The renal biomarkers market size is expected to grow to $1.56 billion in 2027 at a CAGR of 7.7%.

North America held the largest renal biomarkers market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Renal Biomarkers Market Driver ­– Rise In Geriatric And Paediatric Renal Patients
For instance, in March 2021, according to the data published by the Centers for Disease Control and Prevention, a US-based government administrative agency, nearly 37 million adults in the US have chronic renal disease and it is more prevalent in adults 65 years of age and older (38%). Therefore, the rise in geriatric and paediatric renal patients is driving the growth of the renal biomarkers market.

Request for A Sample Of The Global Renal Biomarkers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp

Key Renal Biomarkers Market Trend – Technological Advancement
Major players operating in the renal biomarkers sector is focused on developing innovative technologies to sustain their position in the market. For instance, In January 2021, RenalytixAI, a UK-based developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, partnered with DaVita to develop KidneyIntelX. KidneyIntelX is a diagnostic tool powered by artificial intelligence to help spot those at risk of renal disease or kidney failure. KidneyIntelX uses a machine-learning algorithm to produce a patient-specific risk assessment based on blood biomarkers and electronic medical information.

Renal Biomarkers Market Segment
1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users

Renal Biomarkers Market Major Players and Strategies
Major players in the renal biomarkers market are Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter, Astute Medical Inc., Nexelis, Sphingotec GmbH, Bio-Rad Laboratories, Enzo Biochem Inc., PerkinElmer, and Novartis AG.

In April 2021, Renalytix AI, a US-based biotechnology research company, partnered with the Joslin Diabetes Center to integrate new biomarkers for chronic kidney disease. Through this partnership, Renalytix can enhance the indicators already being collected by KidneyIntelX with a panel of novel biomarkers. KidneyIntelX evaluates the likelihood of adverse kidney outcomes in people with Type 2 diabetes and early kidney disease. Joslin Diabetes Center is a US-based diabetes research centre and diabetes clinic.

The Renal Biomarkers Global Market Report 2023 covers regional data on renal biomarkers market size, renal biomarkers market trends and drivers, opportunities, strategies, and renal biomarkers market competitor analysis. The countries covered in the renal biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Renal biomarker refers to proteins, lipids, genes, metabolites, proteomic patterns, or cells that are found on a urinalysis that is employed to determine the glomerular filtration rate of the kidney, a drop in which indicates kidney damage. The renal biomarkers are used to estimate the nature and severity of kidney injury.

View More Reports Related To The Renal Biomarkers Market –
Biomarkers Global Market Report 2023
Kidney Cancer Drugs Global Market Report 2023
Vascular Grafts Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: